Genome-wide CRISPR activation screen identifies novel receptors for SARS-CoV-2 entry
Shiyou Zhu(Peking University), Wensheng Wei(Peking University), Xia Xiao(Chinese Academy of Medical Sciences & Peking Union Medical College), Feng Tian(Sun Yat-sen University), Shuo Du(China National Petroleum Corporation (China)), Xuran Niu(Peking University), Junyu Xiao(Peking University), Qiheng Li(Tsinghua University), Chunhui Wang(General Hospital of Shenyang Military Region), Jianwei Wang(Zhejiang Cancer Hospital), Ang Chen(Peking University), Zhiying Zhang(Inner Mongolia Medical University), Zhiheng Liu(Peking University), Ying Liu(Fujian Medical University), Shihua Chen(Peking University), Xiaojing Dong(Chinese Academy of Medical Sciences & Peking Union Medical College), Yiyuan Xu(Peking University), Qian Pan(Peking University), Zhuo Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 8
Related Papers
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
|The Lancet|2020|51.8k
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2021|4.3k
Correction: Corrigendum: The Serum Profile of Hypercytokinemia Factors Identified in H7N9-Infected Patients can Predict Fatal Outcomes
|Scientific Reports|2016|2.1k
Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study
|Chinese Medical Journal|2020|1.4k